Pharma Meetings – Face a Changing and Challenging Landscape

Pharma Meetings – Face a Changing and Challenging Landscape

CEO Andy McNeill and client, Christine Damico of Johnson & Johnson, talk about the changing face of pharmaceutical meetings.  With many off-patent drugs coming up, cut-backs are discussed such as the size, length and frequency of face-to-face meetings.  This...